Tesamorelin Research Peptide | 99% Purity | Third Party Tested
Premium quality Tesamorelin research peptide with verified 99% purity, complete documentation, and fast USA shipping. Buy Tesamorelin GHRH analog from a trusted laboratory supplier.
Why Researchers Choose Our Tesamorelin
Our Tesamorelin research peptide represents the gold standard for growth hormone releasing hormone research requiring exceptional purity and documentation. Each vial is manufactured under GMP-aligned protocols with 99% purity verification, comprehensive third-party testing, and complete chain-of-custody documentation.
Key Trust Factors:
- Third-party tested and verified by independent laboratories
- USA manufactured under GMP-aligned procedures
- 99% purity with HPLC and MS verification
- Lot-matched COA included with every order
- Fast shipping with proper cold-chain handling
- Research-grade quality trusted by laboratories nationwide
What is Tesamorelin? Complete Research Overview
Tesamorelin is a synthetic analog of human growth hormone-releasing hormone (GHRH) that incorporates a trans-3-hexenoic acid modification for enhanced stability and prolonged activity. This research peptide has become essential for growth hormone research, metabolic studies, and investigations into HIV-associated lipodystrophy and age-related growth hormone deficiency.
Chemical Properties:
- Molecular Formula: C221H366N72O67S
- Molecular Weight: 5135.86 g/mol
- Structure: 44-amino acid modified GHRH analog
- CAS Number: 218949-48-5
- Purity: 99% (HPLC verified)
- Mechanism: GHRH receptor agonist with enhanced stability
Tesamorelin Research Applications & Mechanisms
Primary Research Focus Areas:
1. Growth Hormone Research Applications
Tesamorelin research demonstrates potent GHRH receptor activation leading to physiological growth hormone release patterns. Studies indicate the compound stimulates pituitary GH secretion while maintaining natural pulsatility in research models and clinical investigations.
2. Lipodystrophy Research Studies
Laboratory studies show Tesamorelin influences adipose tissue distribution and visceral fat reduction through growth hormone-mediated lipolysis, providing insights into fat redistribution mechanisms and metabolic regulation in experimental applications.
3. IGF-1 Research Applications
Research indicates Tesamorelin affects IGF-1 production through enhanced growth hormone secretion, offering insights into the GH/IGF-1 axis and anabolic signaling pathways in various research studies and age-related hormone deficiency models.
4. Cognitive Research Studies
Preclinical studies suggest Tesamorelin may influence cognitive function and memory through growth hormone-mediated mechanisms, providing valuable models for investigating GH effects on brain function and age-related cognitive decline.
Clinical Research & Scientific Studies
Growth Hormone Research Studies
A pivotal study published in Journal of Clinical Endocrinology and Metabolism examined Tesamorelin’s effects on growth hormone secretion in research subjects. Researchers found that Tesamorelin administration produced robust, sustained GH release with maintained physiological characteristics.
Study Results:
- Significant increase in mean GH levels
- Maintained physiological GH pulsatility
- Enhanced IGF-1 and IGFBP-3 levels
- Sustained effect for treatment duration
Lipodystrophy Research Findings
Research published in AIDS demonstrated Tesamorelin’s effects on visceral adipose tissue, showing significant reduction in visceral fat accumulation, improved body composition parameters, enhanced lipolytic activity, and normalized metabolic markers in research subjects with lipodystrophy.
Cognitive Research Applications
Studies in Journal of Clinical Investigation explored Tesamorelin’s influence on cognitive function, demonstrating improved memory performance in aging subjects, enhanced executive function measures, increased hippocampal volume, and correlation between GH levels and cognitive improvements.
Tesamorelin vs Native GHRH: Research Comparison
Property | Tesamorelin | Native GHRH |
---|---|---|
Stability | Enhanced | Very limited |
Half-life | Extended | 7-10 minutes |
Research Applications | Diverse | Limited by instability |
Clinical Development | FDA approved | Research only |
Potency | Enhanced | Standard |
Frequently Asked Questions (FAQ)
Q: What makes Tesamorelin different from other GHRH analogs?
A: Tesamorelin’s trans-3-hexenoic acid modification provides superior stability and extended activity compared to native GHRH, enabling sustained research applications and clinical development.
Q: How pure is your Tesamorelin?
A: Our Tesamorelin exceeds 99% purity as verified by HPLC and mass spectrometry, with complete analytical documentation provided with each batch.
Q: Can Tesamorelin be studied with other growth hormone compounds?
A: Many researchers investigate Tesamorelin in combination with GHRPs, IGF-1, and other growth factors to study synergistic effects on the somatotropic axis.
Research Disclaimer & Legal Notice
Important Research Use Only Statement:
This Tesamorelin research peptide is supplied exclusively for in-vitro laboratory research and scientific investigation purposes. This product is not intended for human consumption, therapeutic use, or clinical application.
RUO disclaimer: For laboratory research use only. Not for human or veterinary consumption or therapeutic applications.